Jun 28, 2025 · 2h 49m · tbpn
Weekly Recap: Tesla Robotaxi, Mr. Beast's AI Tool, Yacine, The Social Network 2, Neuralink Update
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Hosts John Coogan and Jordy Hays break down major weekly developments across technology, defense, and business, featuring in-depth expert interviews on autonomous transport, AI tooling, GLP-1 therapeutics, and Neuralink clinical trials.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 35.1% of the talking time here. How this is scored →
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Yacine Mtibaa flatly dismisses the hosts' suggestion that he raise institutional capital for Dingboard, deriding fundraising and managing people as lame and declaring he would rather operate independently on minimal resources.
Hardest push from the hosts ▶ 29:53 Host Challenges Yacine on Cohere's Strategic ViabilityJohn Coogan directly pushes back against Yacine's claim that Cohere is simply 'based,' pointing out that it conflicts with the dominant industry narrative and requires a serious geopolitical strategy to succeed.
Biggest teaching moment ▶ 1:41:52 Crémieux Details Novo Nordisk's $250 Patent Fee FumbleCrémieux surprises the hosts by explaining how Novo Nordisk failed to pay a minor $250 patent maintenance fee and ignored late fee notices, unlocking Section 804 importation of generic Canadian Ozempic by 2026.
The host holds their own ▶ 1:25:29 Coogan Breaks Down Hims & Hers Financial StatementsJohn Coogan demonstrates clear financial expertise by citing exact revenue, margin progression from -40% to 6.5%, subscriber figures, and post-SPAC valuation multiples for Hims & Hers.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Live Call From Inside a Tesla Robotaxi in Austin | 4 | 4 | 1 | 1 | The hosts interview a live caller riding inside an Austin Tesla Cybercab robotaxi. The caller provides firsthand details on ride smoothness, geofencing, and production cost economics while the hosts ask clarifying questions about hardware modifications. | |
| Analyzing Industrial Scale and Competition in Autonomous Taxis | 5 | 0 | 0 | 0 | Co-hosts Coogan and Hays discuss the industrial scale economics of Tesla versus Waymo and teleoperation overhead. As a co-host commentary segment, no guest schooling or combativeness takes place. | |
| The Social Network 2 and Parody Meta Table Read | 3 | 0 | 0 | 0 | The hosts perform a satirical table read of a parody script for The Social Network 2 involving Mark Zuckerberg and Nat Friedman discussing open-source Llama models. | |
| Interview With Yacine Mtibaa on X, Remote Work, and Dingboard | 5 | 5 | 6 | 4 | Yacine Mtibaa discusses working at X, quitting remote work, and building Dingboard and custom Neovim LLM tooling. He playfully rejects traditional startup tropes, dismissing venture capital, while the hosts try to pitch him on fundraising and secondary transactions. | |
| Geopolitical Updates: Middle East Crisis and Munitions Supply | 6 | 0 | 0 | 0 | Coogan and Hays analyze geopolitical developments involving Iranian strikes, GBU-57 bunker buster munitions capacity, and Polymarket odds in a hosts-only analysis segment. | |
| Mike Gallagher on Defense Strategy, Congress, and Nuclear Energy | 6 | 7 | 2 | 2 | Former Congressman Mike Gallagher gives an in-depth analysis of congressional incentives, the mechanics of presidential power in foreign policy, and Palantir's nuclear software partnership. Gallagher provides nuanced historical perspective on Middle East balance of power and NATO defense spending. | |
| Hims and Hers Stock Plunge After Novo Nordisk Split | 6 | 0 | 0 | 0 | Host commentary reviewing the Hims & Hers stock plunge following the Novo Nordisk partnership breakup, breaking down compounding pharmacy regulatory nuances and Hims financial statements. | |
| Crémieux on the GLP-1 Landscape and Biotech Regulation | 5 | 8 | 3 | 2 | Crémieux educates the hosts on the clinical trial landscape for GLP-1 indications, gray market peptide importing from China, ADHD microdosing use cases, and Novo Nordisk losing its patent fee protection. | |
| Mega-Mergers in Big Oil: Shell and BP Acquisition Talks | 6 | 0 | 0 | 0 | Hosts discuss rumored mega-mergers between Shell and BP, comparing oil M&A deal sizes to Big Tech and recounting the financial impact of Deepwater Horizon. | |
| Debating the Future Strategy of Venture Capital Marketing | 7 | 0 | 0 | 0 | John Coogan and Jordy Hays debate venture capital marketing models, contrasting direct content marketing podcasts with luxury brand positioning and evergreen essays like Peter Thiel's Zero to One and Paul Graham's blog posts. | |
| Tribute to FedEx Founder and Logistics Pioneer Fred Smith | 5 | 0 | 0 | 0 | Hosts read and discuss an obituary honoring FedEx founder Fred Smith, tracing his family background, Yale paper on hub-and-spoke logistics, and military service in Vietnam. | |
| Mr. Beast Thumbnail Tool Rollback and Creator Labor Automation | 6 | 0 | 0 | 0 | The hosts analyze Mr. Beast retracting his ViewStats AI thumbnail tool under pressure from digital artists, arguing against protecting narrow legacy sub-specialties over broad tooling access. | |
| Neuralink Update With DJ Seo on Human Trials and Expansion | 6 | 8 | 1 | 1 | Neuralink founding team member DJ Seo details the technology behind flexible ultra-thin threads, the surgical insertion robot, multi-dimensional decoding in first-person gaming, and Neuralink's recruiting philosophy. |